Merz acquires third aesthetics company within a year, pays $600mm for Ulthera
In its largest acquisition to date, and the third within a year in the aesthetics field, Merz North America Inc. (part of German drug company Merz GMBH & Co. KGAA’s Merz Pharma Group) will pay $600mm in up-front and earn-out payments for privately held Ulthera Inc.
- Medical Devices
Diagnostic Imaging Equipment & Supplies
- Diagnostic Imaging Equipment & Supplies
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.